Contraindicated (1)pentobarbital will lower the extent or result of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is liable for the development and elimination of cariprazine's Lively metabolites. pentobarbital will decrease the level or outcome of bortezomib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe... https://joanq876eui3.livebloggs.com/profile